You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gleevec intolerant

Showing 1 - 25 of 608
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • +3 more
  • Duarte, California
  • +100 more
Jun 8, 2021

PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

Not yet recruiting
  • PCNSL
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jun 8, 2023

Hypercholesterolemia Trial in Japan (K-877 0.2 mg/day (once daily), K-877 0.4 mg/day (once daily), Placebo (once daily))

Recruiting
  • Hypercholesterolemia
  • K-877 0.2 mg/day (once daily)
  • +2 more
  • Aichi, Japan
  • +14 more
Jun 20, 2023

Heart Failure Trial (Finerenone, Placebo)

Not yet recruiting
  • Heart Failure
  • (no location specified)
Sep 11, 2023

Metastatic Colorectal Cancer Trial in Nanjing (Envafolimab, Trifluridine/Tipiracil, Bevacizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 24, 2023

Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 12, 2023

Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

Completed
  • Pancreas Cancer
  • +6 more
  • Rozzano, Milan, Italy
    Istituto Clinico Humanitas
Sep 9, 2022

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)

Not yet recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • ZG006
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Aug 6, 2023

Advanced Solid Tumor Trial in Beijing (SY-3505)

Recruiting
  • Advanced Solid Tumor
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Sep 15, 2023

Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)

Recruiting
  • Healthy (For Part A)
  • Chronic Myeloid Leukemia (for Part B and C)
  • Vodobatinib (K0706) capsules
  • Downey, California
  • +69 more
Dec 7, 2022

Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)

Active, not recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • Newport Beach, California
  • +2 more
Nov 10, 2023

Solid Tumor, Breast Cancer, Pancreatic Cancer Trial in United States (SON-DP)

Recruiting
  • Solid Tumor
  • +4 more
  • Gilbert, Arizona
  • +4 more
Aug 4, 2023

Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

Not yet recruiting
  • Essential Thrombocythemia
  • (no location specified)
Oct 6, 2023

Non-small-cell Lung Carcinoma Trial in Beijing (SY-3505)

Recruiting
  • Non-small-cell Lung Carcinoma
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 11, 2023

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

Active, not recruiting
Has Results
  • Chronic Myeloid Leukemia
  • Los Angeles, California
  • +61 more
Mar 17, 2022

Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))

Not yet recruiting
  • Colorectal Neoplasms
  • Resin microspheres containing yttrium-90 (Y-90)
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023

Lupus Erythematosus, Cutaneous, Subacute, Chronic Cutaneous Lupus Erythematosus Trial (BIIB059 (litifilimab))

Not yet recruiting
  • Lupus Erythematosus, Cutaneous, Subacute
  • Chronic Cutaneous Lupus Erythematosus
  • BIIB059 (litifilimab)
  • (no location specified)
Sep 12, 2023

Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC) Trial in France, Spain, United

Recruiting
  • Unresectable Hepatocellular Carcinoma (HCC)
  • Liver Metastases From Colorectal Cancer (mCRC)
  • SIRT
  • Clichy, Cedex, France
  • +8 more
Jul 31, 2023

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Worldwide (M7824)

Completed
Has Results
  • Biliary Tract Cancer
  • +2 more
  • Scottsdale, Arizona
  • +32 more
Oct 21, 2022

Unresectable Pancreatic Cancer Trial in Sendai-shi, Miyagi, Shinjuku-ku, Tokyo, Yokohama-shi, Kanagawa (Suizenji, Nal-IRI/FL,

Recruiting
  • Unresectable Pancreatic Cancer
  • Suizenji
  • +3 more
  • Sendai-shi, Miyagi, Japan
  • +2 more
Jan 31, 2023

Autoimmune Inner Ear Disease Trial in New Hyde Park (Anakinra 100Mg/0.67Ml Inj Syringe (Period 1), Placebo injection (Period 1),

Recruiting
  • Autoimmune Inner Ear Disease
  • Anakinra 100Mg/0.67Ml Inj Syringe (Period 1)
  • +3 more
  • New Hyde Park, New York
    Northwell Health, Hearing& Speech Center
Oct 18, 2022

Hyperlipidemia Trial in Leuven (Cholesfytol NG®) supplement)

Completed
  • Hyperlipidemia
  • Cholesfytol NG®) supplement
  • Leuven, Belgium
    Cliniques universitaires St-Luc and Institut de Recherche Expéri
Aug 18, 2023

Bladder Cancer Trial (Disitamab Vedotin for Injection,Penpulimab Injection)

Not yet recruiting
  • Bladder Cancer
  • Disitamab Vedotin for Injection,Penpulimab Injection
  • (no location specified)
Aug 2, 2022